December 25, 2024 - 13:50

In a significant move to bolster its struggling economy, Egypt has reached an agreement with the International Monetary Fund (IMF) to access $1.2 billion in financial support. This funding is aimed at addressing the country's strained public finances, which have faced mounting pressures in recent years.
As part of the deal, Egyptian authorities have committed to enhancing their tax-to-revenue ratio, a crucial step in improving fiscal stability. Additionally, the government has pledged to expedite the divestment of state-owned enterprises, a strategy designed to attract private investment and stimulate economic growth.
The agreement underscores the IMF's ongoing role in assisting countries facing economic challenges while highlighting Egypt's determination to implement necessary reforms. With this financial injection, Egypt aims to stabilize its economy, restore investor confidence, and lay the groundwork for sustainable development in the future. The collaboration with the IMF marks a pivotal moment in Egypt's efforts to navigate through its economic difficulties.
February 26, 2026 - 06:37
Pathward Financial Stockholders Re-Elect Directors, Back Say-on-Pay and KPMG at 2026 AGMPathward Financial, Inc. concluded its 2026 Annual Meeting of Stockholders on February 24, with shareholders casting decisive votes on several critical governance matters. The meeting, chaired by...
February 25, 2026 - 22:04
New Retirement Savings Proposal Aims to Expand Worker AccessA new initiative announced by the White House seeks to create retirement savings opportunities for millions of private-sector employees currently lacking access to employer-sponsored plans like 401...
February 25, 2026 - 09:51
A Look At Synchrony Financial (SYF) Valuation After Recent Share Price PullbackSynchrony Financial (SYF) has captured investor focus as its recent share price movement prompts a fresh look at the company`s valuation. The stock recently saw a single-day gain of 2.7%, closing...
February 24, 2026 - 19:13
ADOCIA Reports Fourth Quarter 2025 Financial Results and Provides a Business UpdateLYON, France, February 24, 2026 -- Adocia, a clinical-stage biopharmaceutical company, has announced its financial results for the fourth quarter ending December 31, 2025, alongside a comprehensive...